Korea Pharma ₩1.0bn share buyback via trust contract with broker

Korea Pharma · KOSDAQ · 032300 · Oct 2, 2026 · Share buybacks

Korea Pharma filed a share buyback arranged through a trust contract with NH Investment & Securities, with a contract amount of ₩1.0bn. The contract runs from Oct 6, 2026 to Apr 6, 2027, and the stated purpose is enhancing shareholder value and paying employee stock options. By our calculation, the amount equals 1.1% of FY2025 revenue (₩87.6bn).

Key facts

Acquisition methodTrust contract with a broker
Trust contract amount₩1.0bn
Contract startOct 6, 2026
Contract endApr 6, 2027
PurposeEnhancing shareholder value and paying employee stock options
Contracting brokerNH Investment & Securities Co., Ltd.

Comparison

Amount as % of FY2025 revenue (calculated)1.1%
Revenue 2025₩87.6bn
Revenue 2024₩81.3bn
Revenue 2023₩83.2bn

Key metrics

Share buybacks

Buyback decided, last 3 months₩1.0bn As of Oct 2, 2026 Source 1
Buyback decided, last 3 months, % of sharesNot available
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of sharesNot available
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of sharesNot available
Buyback decided, last 12 months₩1.0bn As of Oct 2, 2026 Source 1
Buyback decided, last 12 months, % of sharesNot available
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of sharesNot available
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of sharesNot available

Source: DART (Financial Supervisory Service) · Original filing on DART ↗ (opens the Financial Supervisory Service's DART site)